English

iMedicor

EDGAR

ICCT Quarterly report (10-Q) · filed 2023-08-14

61 filing records in this dataset, filed from 2008-05-22 to 2023-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.86 million USD

2023 Q2 · USD

Exact inputs and evidence

Revenue: 1856148 USD Source

Operating cash flow

-767 thousand USD

2023 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1919630 USD Source
Operating Cash Flow: -1152215 USD Source

Free cash flow

-905 thousand USD

2023 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1919630 USD Source
Operating Cash Flow: -1152215 USD Source
Capital Expenditure: 178150 USD Source
Capital Expenditure: 40769 USD Source

Cash and cash equivalents: 68.7 thousand USD 2023-06-30 Source
Exact value

68735 USD
Long-term debt including current maturities: 6.91 million USD 2023-06-30 Source
Exact value

6909119 USD
Shares outstanding: 196 million shares 2023-06-30 Source
Exact value

196148863 shares

Reported share-count change

13.73% · 23.7 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

172473691 shares · 2022-06-30· Source
196148863 shares · 2023-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

7.63 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Revenue: 1888768 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 7987902 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 5943818 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 1840371 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 1856148 USD · 2023-04-01 – 2023-06-30 Source

Net income

-7.45 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Net income: -1401976 USD · 2022-07-01 – 2022-09-30 Source
Net income: -6079824 USD · 2022-01-01 – 2022-12-31 Source
Net income: -4431338 USD · 2022-01-01 – 2022-09-30 Source
Net income: -1689034 USD · 2023-01-01 – 2023-03-31 Source
Net income: -2707595 USD · 2023-04-01 – 2023-06-30 Source

Operating cash flow

-1.76 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Operating cash flow: -1675691 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -1434944 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -1272995 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -1675691 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -1152215 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -1919630 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -1152215 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

182 thousand USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Capital expenditure: 0 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 0 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 4153 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 0 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 40769 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 178150 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 40769 USD · 2023-01-01 – 2023-03-31 Source

Free cash flow

-1.94 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Operating cash flow: -1675691 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -1434944 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -1272995 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -1675691 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -1152215 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -1919630 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -1152215 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 0 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 0 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 4153 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 0 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 40769 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 178150 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 40769 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-08-14.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2022-12-31
Operating income: 3 of 11 periods available· newest 2022-12-31
Net income: 10 of 11 periods available· newest 2022-12-31
Operating cash flow: 8 of 11 periods available· newest 2022-12-31
Capital expenditure: 4 of 11 periods available· newest 2022-12-31
Total assets: 7 of 11 periods available· newest 2022-12-31
Total liabilities: 7 of 11 periods available· newest 2022-12-31
Current assets: 7 of 11 periods available· newest 2022-12-31
Current liabilities: 7 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 7 of 11 periods available· newest 2022-12-31
Shares outstanding: 8 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+61.2%

Prior period

USD 4.96 million

2021-01-01 – 2021-12-31
Current period

USD 7.99 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

7987902 − 4956552 = 3031350 USD

4956552 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
7987902 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · iMedicor · 2022-12-31 iMedicor (edgar:1408057) Year-over-year change in Revenue: 3031350 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7987902 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#501034 Filing: 000147793223004637 Input fundies:Revenue: 4956552 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#501601 Filing: 000147793223004637
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.62 million

Prior period

−USD 2.9 million

2021-01-01 – 2021-12-31
Current period

−USD 1.27 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-1272995 − -2896248 = 1623253 USD

-2896248 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-1272995 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · iMedicor · 2022-12-31 iMedicor (edgar:1408057) Year-over-year change in Operating cash flow: 1623253 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1272995 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#650739 Filing: 000147793223004637 Input fundies:OperatingCashFlow: -2896248 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#651433 Filing: 000147793223004637
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-92.5%

Prior period

USD 55,027

2021-01-01 – 2021-12-31
Current period

USD 4,153

2022-01-01 – 2022-12-31

Exact inputs and evidence

4153 − 55027 = -50874 USD

55027 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
4153 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · iMedicor · 2022-12-31 iMedicor (edgar:1408057) Year-over-year change in Capital expenditure: -50874 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4153 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#659090 Filing: 000147793223004637 Input fundies:CapitalExpenditure: 55027 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#659689 Filing: 000147793223004637
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 7.99 million 100% of revenue
Cost of revenue USD 2.24 million 28% of revenue
Operating expenses USD 10.55 million 132% of revenue
Operating income −USD 4.8 million −60% of revenue
Tax, interest and other Derived USD 1.28 million 16% of revenue
Net income −USD 6.08 million −76% of revenue

Cash

Operating cash flow −USD 1.27 million −16% of revenue
Capital expenditure USD 4,153 0.1% of revenue
Free cash flow Derived −USD 1.28 million −16% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Net loss: net income was −164% of revenue.
2021 Operating loss: operating costs were 200% of revenue.
2022 Operating loss: operating costs were 160% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2013-07-01 – 2014-06-30	366447	Unavailable	Unavailable	Unavailable	1953054	Unavailable	Source 2013-07-01 – 2014-06-30: 366447 USD Inspect Revenue Open source 2013-07-01 – 2014-06-30: 1953054 USD Inspect Net Income Open source 2013-07-01 – 2014-06-30: -2463349 USD Inspect Operating Cash Flow Open source
2017 2016-07-01 – 2017-06-30	653000	Unavailable	Unavailable	Unavailable	-4490000	-1752000 Derived	Source 2016-07-01 – 2017-06-30: 653000 USD Inspect Revenue Open source 2016-07-01 – 2017-06-30: -4490000 USD Inspect Net Income Open source 2016-07-01 – 2017-06-30: -1747000 USD Inspect Operating Cash Flow Open source 2016-07-01 – 2017-06-30: 5000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	1089000	Unavailable	Unavailable	Unavailable	-5190000	Unavailable	Source 2018-01-01 – 2018-12-31: 1089000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -5190000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -1969000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: -5000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	1014000	Unavailable	Unavailable	Unavailable	-2983000	Unavailable	Source 2019-01-01 – 2019-12-31: 1014000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -2983000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -1667000 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	2123587	-1367654 Derived	3491241	6982482 Derived	-3491241	Unavailable	Source 2020-01-01 – 2020-12-31: 2123587 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 3491241 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -3491241 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -1270491 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	4956552	9920734 Derived	-4964182	0 Derived	-4964182	-2951275 Derived	Source 2021-01-01 – 2021-12-31: 4956552 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -4964182 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -4964182 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -2896248 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 55027 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	7987902	12790008 Derived	-4802106	1277718 Derived	-6079824	-1277148 Derived	Source 2022-01-01 – 2022-12-31: 7987902 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -4802106 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -6079824 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -1272995 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 4153 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 8M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Revenue	105692	Revenue: 105692 Open source
20142014-06-30	Revenue	366447	Revenue: 366447 Open source
20172017-06-30	Revenue	653000	Revenue: 653000 Open source
20182018-12-31	Revenue	1089000	Revenue: 1089000 Open source
20192019-12-31	Revenue	1014000	Revenue: 1014000 Open source
20202020-12-31	Revenue	2123587	Revenue: 2123587 Open source
20212021-12-31	Revenue	4956552	Revenue: 4956552 Open source
20222022-12-31	Revenue	7987902	Revenue: 7987902 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

61.2% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Year over year	No prior comparable period	Revenue: 105692 Open source
20142014-06-30	Year over year	246.7%	Revenue: 366447 Open source Revenue: 105692 Open source
20172017-06-30	Year over year	No prior comparable period	Revenue: 653000 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 1089000 Open source
20192019-12-31	Year over year	-6.9%	Revenue: 1014000 Open source Revenue: 1089000 Open source
20202020-12-31	Year over year	109.4%	Revenue: 2123587 Open source Revenue: 1014000 Open source
20212021-12-31	Year over year	133.4%	Revenue: 4956552 Open source Revenue: 2123587 Open source
20222022-12-31	Year over year	61.2%	Revenue: 7987902 Open source Revenue: 4956552 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -60.1% 2022

Net margin -76.1% 2022

Free cash flow margin -16% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2013-06-30	Operating margin	Not reported	Revenue: 105692 Open source
2014-06-30	Operating margin	Not reported	Revenue: 366447 Open source
2017-06-30	Operating margin	Not reported	Revenue: 653000 Open source
2018-12-31	Operating margin	Not reported	Revenue: 1089000 Open source
2019-12-31	Operating margin	Not reported	Revenue: 1014000 Open source
20202020-12-31	Operating margin	164.4%	Operating Income: 3491241 Open source Revenue: 2123587 Open source
20212021-12-31	Operating margin	-100.2%	Operating Income: -4964182 Open source Revenue: 4956552 Open source
20222022-12-31	Operating margin	-60.1%	Operating Income: -4802106 Open source Revenue: 7987902 Open source
20132013-06-30	Net margin	-7,787.2%	Net Income: -8230466 Open source Revenue: 105692 Open source
20142014-06-30	Net margin	533%	Net Income: 1953054 Open source Revenue: 366447 Open source
20172017-06-30	Net margin	-687.6%	Net Income: -4490000 Open source Revenue: 653000 Open source
20182018-12-31	Net margin	-476.6%	Net Income: -5190000 Open source Revenue: 1089000 Open source
20192019-12-31	Net margin	-294.2%	Net Income: -2983000 Open source Revenue: 1014000 Open source
2020-12-31	Net margin	Not reported	Revenue: 2123587 Open source
2021-12-31	Net margin	Not reported	Revenue: 4956552 Open source
20222022-12-31	Net margin	-76.1%	Net Income: -6079824 Open source Revenue: 7987902 Open source
20132013-06-30	Free cash flow margin	Not reported	Revenue: 105692 Open source
20142014-06-30	Free cash flow margin	Not reported	Revenue: 366447 Open source Operating Cash Flow: -2463349 Open source
20172017-06-30	Free cash flow margin	-268.3%	Revenue: 653000 Open source Operating Cash Flow: -1747000 Open source Capital Expenditure: 5000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 1089000 Open source Operating Cash Flow: -1969000 Open source Capital Expenditure: -5000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 1014000 Open source Operating Cash Flow: -1667000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 2123587 Open source Operating Cash Flow: -1270491 Open source
20212021-12-31	Free cash flow margin	-59.5%	Revenue: 4956552 Open source Operating Cash Flow: -2896248 Open source Capital Expenditure: 55027 Open source
20222022-12-31	Free cash flow margin	-16%	Revenue: 7987902 Open source Operating Cash Flow: -1272995 Open source Capital Expenditure: 4153 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.3M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Operating cash flow	Not reported	No source recorded
20142014-06-30	Operating cash flow	-2463349	Operating Cash Flow: -2463349 Open source
20172017-06-30	Operating cash flow	-1747000	Operating Cash Flow: -1747000 Open source
20182018-12-31	Operating cash flow	-1969000	Operating Cash Flow: -1969000 Open source
20192019-12-31	Operating cash flow	-1667000	Operating Cash Flow: -1667000 Open source
20202020-12-31	Operating cash flow	-1270491	Operating Cash Flow: -1270491 Open source
20212021-12-31	Operating cash flow	-2896248	Operating Cash Flow: -2896248 Open source
20222022-12-31	Operating cash flow	-1272995	Operating Cash Flow: -1272995 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.3M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Free cash flow	Unavailable	No source recorded
20142014-06-30	Free cash flow	Unavailable	Operating Cash Flow: -2463349 Open source
20172017-06-30	Free cash flow	-1752000	Operating Cash Flow: -1747000 Open source Capital Expenditure: 5000 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1969000 Open source Capital Expenditure: -5000 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1667000 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1270491 Open source
20212021-12-31	Free cash flow	-2951275	Operating Cash Flow: -2896248 Open source Capital Expenditure: 55027 Open source
20222022-12-31	Free cash flow	-1277148	Operating Cash Flow: -1272995 Open source Capital Expenditure: 4153 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

138.2% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Liabilities / assets	2,725.4%	Total Liabilities: 14299704 Open source Total Assets: 524685 Open source
20142014-06-30	Liabilities / assets	658.2%	Total Liabilities: 11344955 Open source Total Assets: 1723520 Open source
2017-06-30	Liabilities / assets	Not reported	No source recorded
20182018-12-31	Liabilities / assets	155.2%	Total Liabilities: 2693000 Open source Total Assets: 1735000 Open source
20192019-12-31	Liabilities / assets	81.6%	Total Liabilities: 2057000 Open source Total Assets: 2522000 Open source
20202020-12-31	Liabilities / assets	123.4%	Total Liabilities: 3319617 Open source Total Assets: 2690677 Open source
20212021-12-31	Liabilities / assets	84.8%	Total Liabilities: 5625052 Open source Total Assets: 6630343 Open source
20222022-12-31	Liabilities / assets	138.2%	Total Liabilities: 9057688 Open source Total Assets: 6556184 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.16× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Current assets / current liabilities	0.06×	Current Assets: 521458 Open source Current Liabilities: 8300269 Open source
20142014-06-30	Current assets / current liabilities	0.09×	Current Assets: 235408 Open source Current Liabilities: 2626696 Open source
2017-06-30	Current assets / current liabilities	Not reported	No source recorded
20182018-12-31	Current assets / current liabilities	0.09×	Current Assets: 234000 Open source Current Liabilities: 2523000 Open source
20192019-12-31	Current assets / current liabilities	0.29×	Current Assets: 554000 Open source Current Liabilities: 1936000 Open source
20202020-12-31	Current assets / current liabilities	0.05×	Current Assets: 154194 Open source Current Liabilities: 3185195 Open source
20212021-12-31	Current assets / current liabilities	0.25×	Current Assets: 1013140 Open source Current Liabilities: 4054246 Open source
20222022-12-31	Current assets / current liabilities	0.16×	Current Assets: 1091668 Open source Current Liabilities: 6798969 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2013-07-01 – 2014-06-30	USD 1.95 million Exact value Exact value: 1953054 USD 2013-07-01 – 2014-06-30: 1953054 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2014-06-30 iMedicor (edgar:1408057) Net Income: 1953054 USD Concept: fundies:NetIncome Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:NetIncome: 1953054 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000135448815005443/vmci-20140630.xml#103447 Filing: 000135448815005443 The citation records this snapshot. The page link may show a newer release later.	−USD 2.46 million Exact value Exact value: -2463349 USD 2013-07-01 – 2014-06-30: -2463349 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · iMedicor · 2014-06-30 iMedicor (edgar:1408057) Operating Cash Flow: -2463349 USD Concept: fundies:OperatingCashFlow Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3AOperatingCashFlow&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2463349 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000135448815005443/vmci-20140630.xml#118026 Filing: 000135448815005443 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	USD 1.95 million Exact value Exact value: 1953054 USD 2014-01-01 – 2014-12-31: 1953054 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2014-12-31 iMedicor (edgar:1408057) Net Income: 1953054 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1953054 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000135448815005443/vmci-20140630.xml#104142 Filing: 000135448815005443 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2017 2016-07-01 – 2017-06-30	−USD 4.49 million Exact value Exact value: -4490000 USD 2016-07-01 – 2017-06-30: -4490000 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2017-06-30 iMedicor (edgar:1408057) Net Income: -4490000 USD Concept: fundies:NetIncome Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:NetIncome: -4490000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793219001309/vmci-20181231.xml#644866 Filing: 000147793219001309 The citation records this snapshot. The page link may show a newer release later.	−USD 1.75 million Exact value Exact value: -1747000 USD 2016-07-01 – 2017-06-30: -1747000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · iMedicor · 2017-06-30 iMedicor (edgar:1408057) Operating Cash Flow: -1747000 USD Concept: fundies:OperatingCashFlow Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3AOperatingCashFlow&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1747000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793219001309/vmci-20181231.xml#631874 Filing: 000147793219001309 The citation records this snapshot. The page link may show a newer release later.	USD 5,000 Exact value Exact value: 5000 USD 2016-07-01 – 2017-06-30: 5000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · iMedicor · 2017-06-30 iMedicor (edgar:1408057) Capital Expenditure: 5000 USD Concept: fundies:CapitalExpenditure Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ACapitalExpenditure&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793219001309/vmci-20181231.xml#632421 Filing: 000147793219001309 The citation records this snapshot. The page link may show a newer release later.	−USD 1.75 million Calculation and evidence -1747000 − 5000 USD Exact free cash flow: -1752000 USD 2016-07-01 – 2017-06-30: -1747000 USD · Inspect Operating Cash Flow · Source 2016-07-01 – 2017-06-30: 5000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · iMedicor · 2017-06-30 iMedicor (edgar:1408057) Free cash flow: -1752000 USD Concept: free-cash-flow Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1747000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793219001309/vmci-20181231.xml#631874 Filing: 000147793219001309 Input fundies:CapitalExpenditure: 5000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793219001309/vmci-20181231.xml#632421 Filing: 000147793219001309 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 5.19 million Exact value Exact value: -5190000 USD 2018-01-01 – 2018-12-31: -5190000 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2018-12-31 iMedicor (edgar:1408057) Net Income: -5190000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5190000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793220001558/icct-20191231.xml#101265 Filing: 000147793220001558 The citation records this snapshot. The page link may show a newer release later.	−USD 1.97 million Exact value Exact value: -1969000 USD 2018-01-01 – 2018-12-31: -1969000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · iMedicor · 2018-12-31 iMedicor (edgar:1408057) Operating Cash Flow: -1969000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1969000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793220001558/icct-20191231.xml#120445 Filing: 000147793220001558 The citation records this snapshot. The page link may show a newer release later.	Unavailable The mapped spending value is negative, so its direction is unclear. Source Inspect Capital Expenditure Open source	Unavailable Capital expenditure has a negative mapped value; spending direction is unclear.
2019 2019-01-01 – 2019-12-31	−USD 2.98 million Exact value Exact value: -2983000 USD 2019-01-01 – 2019-12-31: -2983000 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2019-12-31 iMedicor (edgar:1408057) Net Income: -2983000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2983000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793221007314/icct_s1.htm#925242 Filing: 000147793221007314 The citation records this snapshot. The page link may show a newer release later.	−USD 1.67 million Exact value Exact value: -1667000 USD 2019-01-01 – 2019-12-31: -1667000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · iMedicor · 2019-12-31 iMedicor (edgar:1408057) Operating Cash Flow: -1667000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1667000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793221007314/icct_s1.htm#942447 Filing: 000147793221007314 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 3.49 million Exact value Exact value: -3491241 USD 2020-01-01 – 2020-12-31: -3491241 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2020-12-31 iMedicor (edgar:1408057) Net Income: -3491241 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3491241 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793222002455/icct_10k.htm#556838 Filing: 000147793222002455 The citation records this snapshot. The page link may show a newer release later.	−USD 1.27 million Exact value Exact value: -1270491 USD 2020-01-01 – 2020-12-31: -1270491 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · iMedicor · 2020-12-31 iMedicor (edgar:1408057) Operating Cash Flow: -1270491 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1270491 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793222002455/icct_10k.htm#578529 Filing: 000147793222002455 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-02 – 2020-12-31	−USD 3.49 million Exact value Exact value: -3491241 USD 2020-01-02 – 2020-12-31: -3491241 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2020-12-31 iMedicor (edgar:1408057) Net Income: -3491241 USD Concept: fundies:NetIncome Period: 2020-01-02 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-02&unit=USD&dimensions= Input fundies:NetIncome: -3491241 USD (2020-01-02 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793222002455/icct_10k.htm#500718 Filing: 000147793222002455 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 4.96 million Exact value Exact value: -4964182 USD 2021-01-01 – 2021-12-31: -4964182 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2021-12-31 iMedicor (edgar:1408057) Net Income: -4964182 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4964182 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#577754 Filing: 000147793223004637 The citation records this snapshot. The page link may show a newer release later.	−USD 2.9 million Exact value Exact value: -2896248 USD 2021-01-01 – 2021-12-31: -2896248 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · iMedicor · 2021-12-31 iMedicor (edgar:1408057) Operating Cash Flow: -2896248 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2896248 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#651433 Filing: 000147793223004637 The citation records this snapshot. The page link may show a newer release later.	USD 55,027 Exact value Exact value: 55027 USD 2021-01-01 – 2021-12-31: 55027 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · iMedicor · 2021-12-31 iMedicor (edgar:1408057) Capital Expenditure: 55027 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 55027 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#659689 Filing: 000147793223004637 The citation records this snapshot. The page link may show a newer release later.	−USD 2.95 million Calculation and evidence -2896248 − 55027 USD Exact free cash flow: -2951275 USD 2021-01-01 – 2021-12-31: -2896248 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 55027 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · iMedicor · 2021-12-31 iMedicor (edgar:1408057) Free cash flow: -2951275 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2896248 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#651433 Filing: 000147793223004637 Input fundies:CapitalExpenditure: 55027 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#659689 Filing: 000147793223004637 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-02 – 2021-12-31	−USD 4.96 million Exact value Exact value: -4964182 USD 2021-01-02 – 2021-12-31: -4964182 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2021-12-31 iMedicor (edgar:1408057) Net Income: -4964182 USD Concept: fundies:NetIncome Period: 2021-01-02 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-02&unit=USD&dimensions= Input fundies:NetIncome: -4964182 USD (2021-01-02 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793222002455/icct_10k.htm#547780 Filing: 000147793222002455 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 6.08 million Exact value Exact value: -6079824 USD 2022-01-01 – 2022-12-31: -6079824 USD Inspect Net Income Open source Share or cite Citation for Net Income · iMedicor · 2022-12-31 iMedicor (edgar:1408057) Net Income: -6079824 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6079824 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#619663 Filing: 000147793223004637 The citation records this snapshot. The page link may show a newer release later.	−USD 1.27 million Exact value Exact value: -1272995 USD 2022-01-01 – 2022-12-31: -1272995 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · iMedicor · 2022-12-31 iMedicor (edgar:1408057) Operating Cash Flow: -1272995 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1272995 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#650739 Filing: 000147793223004637 The citation records this snapshot. The page link may show a newer release later.	USD 4,153 Exact value Exact value: 4153 USD 2022-01-01 – 2022-12-31: 4153 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · iMedicor · 2022-12-31 iMedicor (edgar:1408057) Capital Expenditure: 4153 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4153 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#659090 Filing: 000147793223004637 The citation records this snapshot. The page link may show a newer release later.	−USD 1.28 million Calculation and evidence -1272995 − 4153 USD Exact free cash flow: -1277148 USD 2022-01-01 – 2022-12-31: -1272995 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 4153 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · iMedicor · 2022-12-31 iMedicor (edgar:1408057) Free cash flow: -1277148 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408057?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1272995 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#650739 Filing: 000147793223004637 Input fundies:CapitalExpenditure: 4153 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408057/000147793223004637/icct_10k.htm#659090 Filing: 000147793223004637 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

61 filings · 2,462 latest values · 2,462 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001408057, 1408057, ICCT, edgar:1408057

Also known as Vemics, Inc., iCoreConnect Inc., iCoreConnect, Inc., iMedicor

iMedicor

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation